Finance

Roสปyxatlar
Nega BOT oshdi 25,00%?
Batafsil oสปrganish
BOT:ASX
Botanix Pharmaceuticals Ltd
0,010ย A$
+25,00%
(+0,0020) 1K
17-noy, 16:10:06 (GMT+11)  ·   AUD
Barcha belgilar
BelgiNarxiOสปzgartirishlarDinamika (%)
BOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01ย A$
Yuqori
0,01ย A$
Past
0,01ย A$
Bozor kapitali
22,10ย mln
Oสปrtacha hajm
10,87ย mln
Hajmi
10,30ย mln
52 haftalik eng yuqori
0,15ย A$
52 haftalik eng past
0,01ย A$
Aksiya boสปyicha daromad
-0,03ย A$
Muomaladagi aksiyalar
2,76ย mlrd
Xodimlar soni
11
Ochish
0,01ย A$
Yuqori
0,01ย A$
Past
0,01ย A$
Bozor kapitali
22,10ย mln
Oสปrtacha hajm
10,87ย mln
Hajmi
10,30ย mln
52 haftalik eng yuqori
0,15ย A$
52 haftalik eng past
0,01ย A$
Aksiya boสปyicha daromad
-0,03ย A$
Muomaladagi aksiyalar
2,76ย mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida
CEO-
Xodimlar soni11
Asos solingan1984
Bosh ofislar-
SektorHealth Care
Soha-
Oxirgi hisobot
27-iyl, 2026
Moliya davri
Ch.4 2026
- / -
Taxminiy daromad (AUD)
8,65ย mln / -
Q4 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar โ€“ AUD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar โ€“ AUD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
8,25ย mln
8,25ย mln
8,65ย mln
8,65ย mln
Sotilgan mahsulotning tannarxi
2,98ย mln
2,98ย mln
4,19ย mln
4,19ย mln
Daromad narxi
2,98ย mln
2,98ย mln
4,19ย mln
4,19ย mln
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maสผmuriy xarajatlar
18,32ย mln
18,32ย mln
19,70ย mln
19,70ย mln
Operatsion xarajatlar
22,08ย mln
22,08ย mln
22,30ย mln
22,30ย mln
Jami operatsion xarajatlar
25,06ย mln
25,06ย mln
26,49ย mln
26,49ย mln
Operatsion daromad
-16,81ย mln
-16,81ย mln
-17,85ย mln
-17,85ย mln
Boshqa nooperatsion daromad
683,30ย ming
683,30ย ming
109,28ย ming
109,28ย ming
Soliq toสปlangunga qadar foyda, shu jumladan gสปayrioddiy moddalar
-16,60ย mln
-16,60ย mln
-18,29ย mln
-18,29ย mln
Soliq toสปlangunga qadar foyda, gสปayrioddiy moddalar bundan mustasno
-16,60ย mln
-16,60ย mln
-18,29ย mln
-18,29ย mln
Daromad soligสปi boสปyicha xarajat
-
-
-
-
Amaldagi soliq stavkasi
-
-
-
-
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
-16,60ย mln
-16,60ย mln
-18,29ย mln
-18,29ย mln
Sof foyda marjasi
-201,11%
-201,11%
-211,46%
-211,46%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
352,66ย ming
352,66ย ming
202,18ย ming
202,18ย ming
Foizlarni toสปlash xarajatlari
-802,39ย ming
-802,39ย ming
-616,20ย ming
-616,20ย ming
Foizlarni toสปlash boสปyicha sof xarajatlar
-449,74ย ming
-449,74ย ming
-414,02ย ming
-414,02ย ming
Amortizatsiya ajratmalari
593,18ย ming
593,18ย ming
565,11ย ming
565,11ย ming
EBITDA
-16,22ย mln
-16,22ย mln
-17,28ย mln
-17,28ย mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
Kelgusi tadbirlar
AI kontentda xatolar boสปlishi mumkin. Batafsil
Google ilovalari